BioAtla Inc. (BCAB) PT Raised to $8 at Credit Suisse

November 4, 2022 5:52 AM EDT
Get Alerts BCAB Hot Sheet
Price: $3.45 +2.07%

Rating Summary:
    5 Buy, 3 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Credit Suisse analyst Tiago Fauth raised the price target on BioAtla Inc. (NASDAQ: BCAB) to $8.00 (from $4.00) while maintaining a Neutral rating.

You May Also Be Interested In





Related Categories

Analyst PT Change